Serum Institute to begin trials of Oxford's Covid-19 vaccine candidate by Aug-e...

CEO Adar Poonawalla said the company, which is the largest vaccine maker in the world, is putting USD 200 million at risk by manufacturing nearly 300 million doses before the final nod to launch the vaccine in market, which is expected at best by the end of the year.

from Hindustan Times - india https://ift.tt/3hp2i86

Share: